Nrgene Technologies Ltd (NRGN) - Net Assets
Based on the latest financial reports, Nrgene Technologies Ltd (NRGN) has net assets worth ILA2.38 Million ILA (≈ $6.38K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA6.10 Million ≈ $16.36K USD) and total liabilities (ILA3.72 Million ≈ $9.98K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Nrgene Technologies Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA2.38 Million |
| % of Total Assets | 38.99% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 5.88 |
Nrgene Technologies Ltd - Net Assets Trend (2018–2024)
This chart illustrates how Nrgene Technologies Ltd's net assets have evolved over time, based on quarterly financial data. Also explore NRGN current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Nrgene Technologies Ltd (2018–2024)
The table below shows the annual net assets of Nrgene Technologies Ltd from 2018 to 2024. For live valuation and market cap data, see Nrgene Technologies Ltd market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ILA4.01 Million ≈ $10.74K |
-44.47% |
| 2023-12-31 | ILA7.21 Million ≈ $19.34K |
-41.15% |
| 2022-12-31 | ILA12.26 Million ≈ $32.87K |
-30.67% |
| 2021-12-31 | ILA17.68 Million ≈ $47.40K |
+419.90% |
| 2020-12-31 | ILA-5.53 Million ≈ $-14.82K |
-48.34% |
| 2019-12-31 | ILA-3.73 Million ≈ $-9.99K |
-180.78% |
| 2018-12-31 | ILA-1.33 Million ≈ $-3.56K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Nrgene Technologies Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3020400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA38.00K | 0.96% |
| Other Comprehensive Income | ILA6.29 Million | 158.73% |
| Other Components | ILA50.99 Million | 1286.93% |
| Total Equity | ILA3.96 Million | 100.00% |
Nrgene Technologies Ltd Competitors by Market Cap
The table below lists competitors of Nrgene Technologies Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Chimeric Therapeutics Ltd
AU:CHM
|
$8.84 Million |
|
Zeta Network Group
NASDAQ:ZNB
|
$8.84 Million |
|
IQ Group Holdings Bhd
KLSE:5107
|
$8.84 Million |
|
Energy Development Company Limited
NSE:ENERGYDEV
|
$8.84 Million |
|
Ease2pay NV
AS:EAS2P
|
$8.83 Million |
|
Urban Logistics Reit PLC
LSE:SHED
|
$8.83 Million |
|
Libero Copper Corp
V:LBC
|
$8.82 Million |
|
Upergy
PA:ALUPG
|
$8.82 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nrgene Technologies Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,214,000 to 3,962,000, a change of -3,252,000 (-45.1%).
- Net loss of 3,359,000 reduced equity.
- Other comprehensive income decreased equity by 1,595,000.
- Other factors increased equity by 1,702,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-3.36 Million | -84.78% |
| Other Comprehensive Income | ILA-1.59 Million | -40.26% |
| Other Changes | ILA1.70 Million | +42.96% |
| Total Change | ILA- | -45.08% |
Book Value vs Market Value Analysis
This analysis compares Nrgene Technologies Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 803.25x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | ILA-0.15 | ILA253.40 | x |
| 2019-12-31 | ILA-0.43 | ILA253.40 | x |
| 2020-12-31 | ILA-0.63 | ILA253.40 | x |
| 2021-12-31 | ILA1.46 | ILA253.40 | x |
| 2022-12-31 | ILA0.98 | ILA253.40 | x |
| 2023-12-31 | ILA0.57 | ILA253.40 | x |
| 2024-12-31 | ILA0.32 | ILA253.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nrgene Technologies Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -84.78%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -260.39%
- • Asset Turnover: 0.21x
- • Equity Multiplier: 1.51x
- Recent ROE (-84.78%) is below the historical average (-36.46%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | -61.45% | 1.56x | 0.00x | ILA-4.36 Million |
| 2019 | 0.00% | -51.41% | 1.81x | 0.00x | ILA-3.54 Million |
| 2020 | 0.00% | -44.72% | 1.85x | 0.00x | ILA-2.59 Million |
| 2021 | -47.16% | -186.83% | 0.17x | 1.49x | ILA-10.11 Million |
| 2022 | -50.63% | -196.49% | 0.18x | 1.41x | ILA-7.43 Million |
| 2023 | -72.68% | -262.02% | 0.19x | 1.50x | ILA-5.96 Million |
| 2024 | -84.78% | -260.39% | 0.21x | 1.51x | ILA-3.76 Million |
Industry Comparison
This section compares Nrgene Technologies Ltd's net assets metrics with peer companies in the Software - Application industry.
Industry Context
- Industry: Software - Application
- Average net assets among peers: $92,521,634
- Average return on equity (ROE) among peers: -35.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nrgene Technologies Ltd (NRGN) | ILA2.38 Million | 0.00% | 1.56x | $8.84 Million |
| Abra Information Technologies (ABRA) | $46.03 Million | 39.39% | 0.38x | $117.71 Million |
| Idomoo Ltd (IDMO) | $-8.20 Million | 0.00% | 0.00x | $14.65 Million |
| Nice Ltd (NICE) | $167.02 Million | -28.02% | 0.26x | $4.89 Billion |
| One Software Technologies Ltd (ONE) | $326.75 Million | 25.22% | 2.16x | $1.31 Billion |
| Photomyne Ltd (PHTM) | $3.69 Million | -133.70% | 2.41x | $14.46 Million |
| Sarine Technologies Ltd (SARN) | $67.33 Million | 35.48% | 0.21x | $42.77 Million |
| Synel M.L.L Payway Ltd (SNEL) | $200.61 Million | 13.56% | 1.76x | $27.57 Million |
| Sapiens International Corporation NV (SPNS) | $12.08 Million | -40.08% | 4.69x | $2.09 Billion |
| Tectona (TECT) | $17.39 Million | -231.96% | 0.16x | $17.77 Million |
About Nrgene Technologies Ltd
NRGene Technologies Ltd operates as a research and development company focusing on intellectual property-intensive technological products in the field of AgTech in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally. It develops and commercializes plant varieties, traits, and animals based on artificial intelligence (AI) technology and software tools for analyzing ge… Read more